Related Experiment Videos
Oncological aspects of breast reconstruction
C W Taylor1, K Horgan, D Dodwell
1Cookridge Hospital, Hospital Lane, Leeds LS16 6QB, UK.
Breast (Edinburgh, Scotland)
|March 16, 2005
Summary
Breast reconstruction is oncologically safe, not hindering cancer survival or adjuvant treatments. Studies show it does not mask recurrence or delay chemotherapy, though radiation may affect implants.
Area of Science:
- Oncology
- Plastic Surgery
Background:
- Breast reconstruction popularity has surged in the last two decades.
- Concerns exist regarding potential masking of locoregional recurrence and interference with adjuvant treatments.
Purpose of the Study:
- To review existing evidence on the oncological safety of breast reconstruction.
- To assess the impact of breast reconstruction on disease-free survival, overall survival, and adjuvant treatment delivery.
Main Methods:
- Systematic review of retrospective studies.
- Analysis of literature focusing on breast reconstruction outcomes.
- Comparison of chemotherapy delivery in patients with and without immediate reconstruction.
Main Results:
- Most studies suggest breast reconstruction does not negatively impact disease-free or overall survival.
- No significant delay in the presentation of recurrent disease was observed.
- Chemotherapy delivery and dose intensity were not compromised by immediate breast reconstruction.
- Radiation therapy can increase capsular contracture rates for prosthetic implants but is generally well-tolerated with autogenous tissue reconstruction.
Conclusions:
- Breast reconstruction appears oncologically safe.
- It does not adversely affect survival outcomes or delay cancer detection.
- Careful consideration of radiation effects is necessary for prosthetic reconstructions.